Literature DB >> 10377443

Constitutive cell surface association between CD4 and CCR5.

X Xiao1, L Wu, T S Stantchev, Y R Feng, S Ugolini, H Chen, Z Shen, J L Riley, C C Broder, Q J Sattentau, D S Dimitrov.   

Abstract

HIV-1 entry into cells involves formation of a complex between gp120 of the viral envelope glycoprotein (Env), a receptor (CD4), and a coreceptor. For most strains of HIV, this coreceptor is CCR5. Here, we provide evidence that CD4 is specifically associated with CCR5 in the absence of gp120 or any other receptor-specific ligand. The amount of CD4 coimmunoprecipitated with CCR5 was significantly higher than that with the other major HIV coreceptor, CXCR4, and in contrast to CXCR4 the CD4-CCR5 coimmunoprecipitation was not significantly increased by gp120. The CD4-CCR5 interaction probably takes place via the second extracellular loop of CCR5 and the first two domains of CD4. It can be inhibited by CCR5- and CD4-specific antibodies that interfere with HIV-1 infection, indicating a possible role in virus entry. These findings suggest a possible pathway of HIV-1 evolution and development of immunopathogenicity, a potential new target for antiretroviral drugs and a tool for development of vaccines based on Env-CD4-CCR5 complexes. The constitutive association of a seven-transmembrane-domain G protein-coupled receptor with another receptor also indicates new possibilities for cross-talk between cell surface receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10377443      PMCID: PMC22114          DOI: 10.1073/pnas.96.13.7496

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  Evidence for cell-surface association between fusin and the CD4-gp120 complex in human cell lines.

Authors:  C K Lapham; J Ouyang; B Chandrasekhar; N Y Nguyen; D S Dimitrov; H Golding
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

3.  The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.

Authors:  H Choe; M Farzan; Y Sun; N Sullivan; B Rollins; P D Ponath; L Wu; C R Mackay; G LaRosa; W Newman; N Gerard; C Gerard; J Sodroski
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

4.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

5.  Several CD4 domains can play a role in human immunodeficiency virus infection in cells.

Authors:  L Poulin; L A Evans; S B Tang; A Barboza; H Legg; D R Littman; J A Levy
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

6.  Phorbol ester-induced down modulation of tailless CD4 receptors requires prior binding of gp120 and suggests a role for accessory molecules.

Authors:  H Golding; D S Dimitrov; J Manischewitz; C C Broder; J Robinson; S Fabian; D R Littman; C K Lapham
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s).

Authors:  C C Broder; D S Dimitrov; R Blumenthal; E A Berger
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

8.  Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation.

Authors:  O Nussbaum; C C Broder; E A Berger
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Cell fusion mediated by interaction of a hybrid CD4.CD8 molecule with the human immunodeficiency virus type 1 envelope glycoprotein does occur after a long lag time.

Authors:  H Golding; R Blumenthal; J Manischewitz; D R Littman; D S Dimitrov
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

10.  T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression.

Authors:  C H June; J A Ledbetter; M M Gillespie; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

View more
  54 in total

1.  Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection.

Authors:  S Mañes; G del Real; R A Lacalle; P Lucas; C Gómez-Moutón; S Sánchez-Palomino; R Delgado; J Alcamí; E Mira; C Martínez-A
Journal:  EMBO Rep       Date:  2000-08       Impact factor: 8.807

2.  CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.

Authors:  I I Singer; S Scott; D W Kawka; J Chin; B L Daugherty; J A DeMartino; J DiSalvo; S L Gould; J E Lineberger; L Malkowitz; M D Miller; L Mitnaul; S J Siciliano; M J Staruch; H R Williams; H J Zweerink; M S Springer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Physiological coreceptor use by dual-tropic HIV-1: one plus one equals one.

Authors:  B J Rollins
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

4.  Pharmacological characterization of the chemokine receptor, CCR5.

Authors:  Anja Mueller; Nasir G Mahmoud; Marc C Goedecke; Jane A McKeating; Philip G Strange
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

5.  Localization of CD4 and CCR5 in living cells.

Authors:  Carolyn M Steffens; Thomas J Hope
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

6.  Membrane fusion mediated by coiled coils: a hypothesis.

Authors:  J Bentz
Journal:  Biophys J       Date:  2000-02       Impact factor: 4.033

7.  Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.

Authors:  José Miguel Rodríguez-Frade; Gustavo del Real; Antonio Serrano; Patricia Hernanz-Falcón; Silvia F Soriano; Antonio J Vila-Coro; Ana Martín de Ana; Pilar Lucas; Ignacio Prieto; Carlos Martínez-A; Mario Mellado
Journal:  EMBO J       Date:  2003-12-11       Impact factor: 11.598

8.  Sequential CD4-coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120.

Authors:  K Salzwedel; E D Smith; B Dey; E A Berger
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 9.  Rational design of novel HIV-1 entry inhibitors by RANTES engineering.

Authors:  Luca Vangelista; Massimiliano Secchi; Paolo Lusso
Journal:  Vaccine       Date:  2008-01-10       Impact factor: 3.641

10.  CD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.

Authors:  G Lin; B Lee; B S Haggarty; R W Doms; J A Hoxie
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.